Sarilumab in Patients Admitted to the Hospital With Severe COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sarilumab in Patients Admitted to Hospital With Severe or Critical COVID-19: A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
Lancet Respir Med 2021 Mar 04;[EPub Ahead of Print], FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, O HaginoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.